Overview

A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging

Status:
Recruiting

Trial end date:
2023-07-14

Target enrollment:

Participant gender:

Summary

The purpose of the study is to assess the effects of selexipag on right ventricular (RV) function in participants with Pulmonary arterial hypertension (PAH).

Phase:

Phase 4

Details

Lead Sponsor:

Actelion

Treatments:

Selexipag